Idiosyncratic Drug–induced Neutropenia Secondary to Ofatumumab Exposure in Multiple Sclerosis: A Case Report and Analysis of Food and Drug Administration Adverse Event Reporting System (P8-1.012)

Sam Hooshmand(Medical College of Wisconsin), Michelle Maynard(Froedtert Hospital), Uzoma Wamuo(Indiana University School of Medicine)
Neurology
April 7, 2025
Cited by 1


Related Papers